Mohs Surgery for Periocular Basal Cell Carcinoma Without a Mohs Surgeon: The First Series in Hong Kong
Authors:
Open Access
- 16 March 2023
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 15 (3)
Abstract
Purpose To report the first series of Mohs micrographic surgery (MMS) in Hong Kong, where the roles of a Mohs surgeon were shared and coordinated by a “mobile” surgeon. Methods Design: Prospective non-comparative interventional case series. Subjects: 20 consecutive Chinese patients (10 male, age 78.5+10.4 years, range 55-91 years) with primary periocular basal cell carcinoma (pBCC) referred to the university oculoplastic unit between October 2007 and August 2013. Intervention: MMS were conducted according to a streamlined standard operating procedure emphasizing surgeon-driven mapping, specimen orientation, and on-site clinico-histological correlation with the dermatopathologist at the frozen-section laboratory. Main Outcome Measures: Clinical and histological characteristics of tumors, layers of Mohs procedures, complications, and biopsy-confirmed recurrence at the same location. Results All 20 patients received MMS as planned. Sixteen pBCCs (80%) were diffusely pigmented, and three (15%) were focally pigmented. Sixteen were also nodular. The average tumor diameter was 7+3 (3-15) mm. Seven (35%) were within 2 mm of the punctum. Histologically, 11 (55%) were nodules, and four (20%) were superficial. An average of 1.8+0.8 Mohs levels were performed. Apart from the initial two patients, who required four and three levels, respectively, seven (35%) patients were cleared after the first level of MMS using a 1mm clinical margin. The remaining 11 patients required two levels with an additional 1-2mm margin, but only focally as guided histologically. Defects in 16 patients (80%) were reconstructed by local flaps, two by direct closure, and two with pentagon closure. Among the seven patients with pericanalicular BCC, three patients had their remaining canaliculi successfully intubated, while two developed stenotic upper and two lower punctae postoperatively. One patient had prolonged wound healing. Three patients had lid margin notching, two had medial ectropion, one had medial canthal rounding, and two had lateral canthal dystopia. No recurrence was detected at a mean follow-up of 80+23 months (43 to 113 months) in all patients. Conclusions MMS was successfully introduced in Hong Kong without a Mohs surgeon. Providing complete microscopic margin control and preserving tissues, it was proven to be a valuable treatment option for pBCC. Our multidisciplinary protocol demonstrated that these merits are possible and warrant validation in other resource-limited healthcare settings.Keywords
This publication has 28 references indexed in Scilit:
- Malignant eyelid tumors in Hong Kong 1997–2009Japanese Journal of Ophthalmology, 2011
- Globe-Sparing Surgery for Medial Canthal Basal Cell Carcinoma with Anterior Orbital InvasionOphthalmology, 2010
- Randomized Comparison of Mohs Micrographic Surgery and Surgical Excision for Small Nodular Basal Cell CarcinomaDermatologic Surgery, 2009
- Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closureBritish Journal of Ophthalmology, 2008
- Difference between Pigmented and Nonpigmented Basal Cell Carcinoma Treated with Mohs Micrographic SurgeryDermatologic Surgery, 2006
- Skin cancer in skin of colorJournal of the American Academy of Dermatology, 2006
- Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005
- Management of Periocular Basal Cell Carcinoma With Modified En Face Frozen Section Controlled ExcisionOphthalmic Plastic & Reconstructive Surgery, 2002
- Treatment options and future prospects for the management of eyelid malignancies An evidence-based updateOphthalmology, 2001
- Pigmented basal cell carcinoma: Investigation of 70 casesJournal of the American Academy of Dermatology, 1992